Organization
Yanru Wang
1 clinical trial
Clinical trial
An Exploratory Clinical Study of the Safety and Efficacy of CD19 Chimeric Antigen Receptor NK Cell Injections for the Treatment of Relapsed/Refractory B-cell Related Autoimmune DiseasesStatus: Recruiting, Estimated PCD: 2025-03-13